BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The net proceeds will be used to purchase gold bullion in accordance with its investment policy and for general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Public Offering
BioSig Technologies, Inc. intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used to purchase gold bullion and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering is subject to market conditions with uncertainty regarding timing, size, or terms.
- Investors interested should read the preliminary prospectus supplement and accompanying base prospectus for detailed information.
- The offering is being made pursuant to a shelf registration statement declared effective by the SEC.
BioSig Technologies Inc. aims to raise funds through a public offering, highlighting the use of proceeds for gold bullion purchase and corporate purposes.